Squarepoint Ops LLC purchased a new position in Delek US Holdings, Inc. (NYSE:DK - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 46,288 shares of the oil and gas company's stock, valued at approximately $856,000. Squarepoint Ops LLC owned 0.07% of Delek US at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Systematic Financial Management LP grew its stake in shares of Delek US by 9.9% in the fourth quarter. Systematic Financial Management LP now owns 913,890 shares of the oil and gas company's stock worth $16,907,000 after purchasing an additional 82,039 shares during the last quarter. Snowden Capital Advisors LLC grew its position in shares of Delek US by 94.4% in the 4th quarter. Snowden Capital Advisors LLC now owns 32,086 shares of the oil and gas company's stock worth $594,000 after buying an additional 15,582 shares during the last quarter. Rafferty Asset Management LLC increased its stake in shares of Delek US by 0.7% during the fourth quarter. Rafferty Asset Management LLC now owns 114,701 shares of the oil and gas company's stock valued at $2,122,000 after buying an additional 797 shares during the period. ProShare Advisors LLC raised its holdings in shares of Delek US by 49.0% during the fourth quarter. ProShare Advisors LLC now owns 17,857 shares of the oil and gas company's stock valued at $330,000 after acquiring an additional 5,874 shares in the last quarter. Finally, Nuveen Asset Management LLC lifted its stake in Delek US by 21.9% in the fourth quarter. Nuveen Asset Management LLC now owns 1,005,309 shares of the oil and gas company's stock worth $18,598,000 after acquiring an additional 180,498 shares during the period. Institutional investors own 97.01% of the company's stock.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on DK shares. UBS Group reduced their price objective on shares of Delek US from $21.00 to $13.25 and set a "neutral" rating on the stock in a research report on Wednesday, April 9th. Scotiabank cut their target price on shares of Delek US from $24.00 to $14.00 and set a "sector perform" rating on the stock in a research note on Friday, April 11th. Morgan Stanley boosted their price target on shares of Delek US from $14.00 to $15.00 and gave the company an "underweight" rating in a research report on Monday, May 19th. Piper Sandler lowered their price objective on shares of Delek US from $18.00 to $17.00 and set a "neutral" rating for the company in a report on Friday, March 7th. Finally, Raymond James cut their price objective on Delek US from $24.00 to $23.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Five equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $17.27.
View Our Latest Research Report on Delek US
Delek US Stock Up 2.4%
DK traded up $0.45 during midday trading on Tuesday, reaching $19.29. The company's stock had a trading volume of 1,599,440 shares, compared to its average volume of 1,307,421. Delek US Holdings, Inc. has a 1 year low of $11.03 and a 1 year high of $25.83. The stock's 50-day moving average is $15.12 and its 200-day moving average is $16.78. The firm has a market capitalization of $1.17 billion, a price-to-earnings ratio of -3.97 and a beta of 0.74. The company has a current ratio of 1.04, a quick ratio of 0.67 and a debt-to-equity ratio of 3.18.
Delek US (NYSE:DK - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The oil and gas company reported ($2.32) EPS for the quarter, missing analysts' consensus estimates of ($2.27) by ($0.05). Delek US had a negative return on equity of 28.21% and a negative net margin of 2.27%. The company had revenue of $2.64 billion during the quarter, compared to the consensus estimate of $2.56 billion. During the same period in the prior year, the firm earned ($0.41) earnings per share. The business's revenue for the quarter was down 18.1% compared to the same quarter last year. As a group, research analysts expect that Delek US Holdings, Inc. will post -5.5 EPS for the current year.
Delek US Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, May 19th. Stockholders of record on Monday, May 12th were paid a $0.255 dividend. The ex-dividend date was Monday, May 12th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 5.29%. Delek US's dividend payout ratio is currently -9.18%.
Insider Activity at Delek US
In other Delek US news, CFO Mark Wayne Hobbs bought 2,800 shares of the business's stock in a transaction on Tuesday, March 11th. The shares were acquired at an average cost of $13.70 per share, for a total transaction of $38,360.00. Following the purchase, the chief financial officer now owns 49,138 shares in the company, valued at approximately $673,190.60. This trade represents a 6.04% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last ninety days, insiders have bought 5,055 shares of company stock valued at $70,787. 1.80% of the stock is owned by insiders.
Delek US Profile
(
Free Report)
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
Read More

Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.